Kiran P. Amancha,Chandeshwari S. Chilampalli,Venkat R. Goskonda
申请号：
US15336547
公开号：
US09918981B2
申请日:
2016.10.27
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The invention provides liquid formulations containing buprenorphine, a pharmaceutically acceptable salt thereof, or a derivative thereof. The invention further provides liquid formulations containing buprenorphine and naloxone, pharmaceutically acceptable salts thereof or derivatives thereof. The invention further provides a method of treating pain or opioid dependence by administering liquid formulations containing buprenorphine or a combination of buprenorphine and naloxone, a pharmaceutically acceptable salt thereof, or a derivative thereof to a patient in need thereof.
